The company aims to combine the liquid nasal formulation and SPC-15’s novel protocol intended for the treatment and prevention of anxiety, PTSD and other stress-related disorders. Silo Pharma ...

Such experiences often lead to PTSD, depression, anxiety, emotion dysregulation, substance misuse, and difficulties in relationships. Through individualized case-formulation, my approach assists ...

The development means the sublingually delivered therapy for PTSD should begin double-blind, placebo-controlled Phase II trials in Q3 2014, Tonix said in a statement. It aims to be the first to ...

SPC-15, a Serotonin 4 receptor agonist with prophylactic efficacy against stress, utilizes biomarkers for the treatment of stress-induced affective disorders, anxiety, and PTSD. Its core ...

BNC210 novel oral tablet formulation (900 mg given twice daily) exceeds blood exposure projected for upcoming Phase 2b PTSD trial BNC210 Phase 2b PTSD trial on target for start in mid-2021 with ...

Resyca is a joint venture between Bespak Group and Medspray Pharma BV, which manufactures the formulation-specific ... for post-traumatic stress disorder (PTSD). “The patented nasal spray ...